CY
Not verified

CYBIN Inc.

What we write about

BiotechnologyHealthMedicine - variousPharmaceuticalsPsychiatry
13/06/2025
Alternative Medicine
Psychiatry
Health
Medicine - various
Pharmaceuticals
Biotechnology
Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics
1.00
12/06/2025
Alternative Medicine
Psychiatry
Health
Sanità
Pharmaceuticals
Biotechnology
WEB AND SOCIAL NETWORK
Eventi
Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference
1.00
11/06/2025
Eventi
Biotechnology
Psychiatry
Health
Medicine - various
Cybin to Participate in the 2025 Psychedelic Science Conference
1.00
03/06/2025
Psychiatry
Scienza
Biotechnology
Sanità
Alternative Medicine
Health
Pharmaceuticals
Industria
Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder
1.00
22/05/2025
Eventi
WEB AND SOCIAL NETWORK
Psychiatry
Scienza
Biotechnology
Sanità
Alternative Medicine
Health
Pharmaceuticals
Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025
1.00
20/05/2025
Labour market
Industria
Psychiatry
Scienza
Food hygiene
Medicine - various
Sanità
Health
Pharmaceuticals
Cybin Applauds FDA Commissioner Dr. Martin Makary’s Call to Accelerate and Prioritize Research on Psychedelic Therapeutics
1.00
15/05/2025
Labour market
Industria
Psychiatry
Health
Sanità
Medicine - various
Pharmaceuticals
Biotechnology
Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder
1.00
14/05/2025
WEB AND SOCIAL NETWORK
Industria
Eventi
Alternative Medicine
Psychiatry
Health
Medicine - various
Pharmaceuticals
Biotechnology
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
1.00
08/05/2025
Industria
Alternative Medicine
Psychiatry
Health
Medicine - various
Pharmaceuticals
Biotechnology
Cybin Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder
1.00
01/05/2025
WEB AND SOCIAL NETWORK
Eventi
Pharmaceuticals
Health
Psychiatry
Cybin to Participate at the 28th Annual Milken Institute Global Conference
1.00

Contact details

Social Media

Followers
0
Compatibility
0